Evidence map›Paper›PMID 42282907›Full record

ReviewClinical parkinsonism & related disorders2026

Structural covariance network alterations across the spectrum of cognitive status in Parkinson's disease.

Haruto Shibata, Yuto Uchida, Keita Sakurai, Ken Tanaka, Yuya Kano, Noriyuki Matsukawa

Abstract readReview
In one paragraph

Review in Clinical parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haruto ShibataDepartment of Neurology, Nagoya City University East Medical Center, 1-2-23 Wakamizu, Chikusa-ku, Nagoya 464-8547, Japan.
Yuto UchidaDepartment of Neurology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
Keita SakuraiDepartment of Radiology, NHO Higashinagoya National Hospital, 5-101, Umemorizaka, Meito-ku, Nagoya 465-8620, Japan.
Ken TanakaDepartment of Public Health, University of Hawaii at Manoa, Honolulu, USA.
Yuya KanoDepartment of Neurology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
Noriyuki MatsukawaDepartment of Neurology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Parkinson's disease (PD) is a neurodegenerative disorder in which cognitive impairment frequently emerges as the disease progresses. Structural covariance network (SCN) analysis provides a framework for characterizing large-scale brain network organization beyond regional atrophy. This study aimed to assess alterations in SCN topology across the cognitive spectrum of PD. Methods: We retrospectively reviewed 16 healthy controls (HC), 20 patients with PD and normal cognition (PD-CN), and 22 patients with PD and mild cognitive impairment (PD-MCI). Cortical thickness-based SCNs were constructed, and graph-theoretical analyses were performed to assess global network metrics, nodal centrality, and modular organization. Results: Using a bootstrap-based area-under-the-curve framework ( Conclusions: SCN analysis revealed stage-dependent network reorganization in PD, suggesting the utility of network-based approaches for characterizing large-scale brain alterations related to cognitive impairment.

Indexed as

Mild cognitive impairmentParkinson's diseaseStructural covariance network

Identifiers

PMID42282907
PMCPMC13251637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.